Tumor News and Research

RSS

New target of a cancer-causing gene

Researchers from the Johns Hopkins Bloomberg School of Public Health and other institutions have identified a new target of a cancer-causing gene.

27 May 2004

New technology gives neurosurgeons real-time images in the operating room

Within the past decade, imaging systems have provided much clearer pictures of the brain’s structures, and navigational tools have helped physicians map direct approaches, minimize points of entry and spare healthy brain and function.

27 May 2004

Evidence that abnormally short telomeres play a role in the early development of cancer

Scientists at the Johns Hopkins Kimmel Cancer Center say they have evidence that abnormally short telomeres - the end-caps on chromosomes that normally preserve genetic integrity -appear to play a role in the early development of many types of cancer.

27 May 2004

Men with low prostate specific antigen levels on screening tests can still have prostate cancer

Men with low PSA (prostate specific antigen) levels on screening tests can still have prostate cancer, according to a study* released today by scientists from the National Cancer Institute (NCI).

27 May 2004

3 or 4 glasses of wine a week can kill cancer cells

It’s well known that drinking red wine in moderation can have some health benefits, mainly attributed to a compound called resveratrol. Now, scientists at the University of Virginia Health System have discovered how.

25 May 2004

Results from a clinical study of CyberKnife ® radiosurgery for locally advanced pancreatic cancer

Accuray Incorporated announced today the publication of the results from a clinical study of CyberKnife ® radiosurgery for locally advanced pancreatic cancer.

25 May 2004

People in Michigan with low incomes may be more likely to develop brain cancer

The study, which looked at more than 1,000 cases of people with brain cancer during a two-year period (1996-1997), was published in the recent edition of Neurology, the scientific journal of the American Academy of Neurology.

25 May 2004

Antioxidant compound found in green tea leaves does not clear established plaque

Using a technique that enables them to study both early and advanced stages of arterial plaque buildup in the same mice, researchers at Cedars-Sinai Medical Center found that an antioxidant compound found in green tea leaves does not clear established plaque but does inhibit the development of new deposits.

24 May 2004

People with low incomes are more likely to develop brain cancer

People with low incomes are more likely to develop brain cancer, according to a study published in the May 25 issue of Neurology, the scientific journal of the American Academy of Neurology.

24 May 2004

Largest study ever finds male breast cancer on the rise

The rate of male breast cancer is on the rise and the disease in men is usually detected when the tumors are bigger, have spread and may be more aggressive, compared to diagnosis of the disease in women, concludes the largest study ever conducted of male breast cancer.

24 May 2004

African-Americans more likely to die of colon cancer

African-Americans with colon cancer are more than 50 percent more likely to die of their cancer within five and ten years after surgery than Caucasians. According to a new study published May 24, 2004 in the online edition of CANCER.

24 May 2004

Study finds breast cancer in men is increasing though the disease remains rare

The largest study to date of male breast cancer finds, contrary to previous reports, breast cancer rates in men are increasing though the disease remains rare.

23 May 2004

Combination radiation treatment for brain cancer leads to better life

People with cancer that has spread to the brain – about 40 percent of all cancer cases – live longer and enjoy a better quality of life if they are treated with a combination of radiation techniques, according to research conducted, in part, at the James P. Wilmot Cancer Center at the University of Rochester Medical Center.

21 May 2004

Tumour suppressor gene family may be key to new colon cancer drugs

In the hunt for new cancer drug targets, scientists from the Johns Hopkins Kimmel Cancer Center and the Howard Hughes Medical Institute have discovered mutations in a family of genes linked to more than a quarter of colon cancers, as well as several other common cancers including breast and lung.

20 May 2004

New study of tumor genetics may help to treat patients with head and neck cancer

Head and neck tumors account for more than 40,000 new cancers annually in the United States. The most common of these is squamous cell carcinoma. Prognosis is based largely on location and size of the tumor, and if the cancer has spread, or metastasized, to lymph nodes and distant sites in the body.

19 May 2004

Drug combo effective for advanced breast cancer

A pair of studies at UCLA's Jonsson Cancer Center that takes laboratory science to the patients' bedside found that combining the molecularly targeted therapy Herceptin with a specific chemotherapy combination resulted in significant tumor response rates and longer relapse-free periods in women with an aggressive form of advanced breast cancer.

19 May 2004

Study comparing the efficacy of REMICADE® to Azathioprine alone and in combination With REMICADE®

Centocor, Inc., and Schering-Plough Corporation announced today the initiation of the SONIC (Study of Immunomodulator Naive patients in Crohn's Disease) trial that will evaluate the efficacy of REMICADE® (infliximab) versus azathioprine, a conventional immunosuppressive agent, alone and versus the combination of both drugs for the treatment of patients with Crohn's disease.

18 May 2004

Interventional radiologists now are able to treat using minimally invasive procedures

Interventional radiologists at Temple University Hospital now are able to treat many patients with minimally invasive procedures not available only a few years ago. “Conditions that used to require extensive surgery now take an hour or less, and patients leave with a bandaid and walk home,” says Gary Cohen, M.D., Section Chief of Interventional Radiology and Vice Chairman of Radiology. “How can you beat that?”

17 May 2004

Glucose metabolism could be used to selectively destroy cancer cells

Scientists have known for decades that cancer cells consume more glucose than normal cells. A longstanding assumption that the excess glucose metabolism was needed to make energy has not been borne out by research studies.

15 May 2004

Genetically engineered viruses may create new class of cancer therapies

A genetically engineered virus can selectively kill cancerous cells in the lung and colon while leaving healthy cells intact, according to new research published today in Cancer Research by William Wold and colleagues at Saint Louis University School of Medicine.

15 May 2004